Journal Mobile Options
Table of Contents
Vol. 62, No. 4, 2006
Issue release date: November 2006
Gynecol Obstet Invest 2006;62:206–216
(DOI:10.1159/000094005)

Implantation of the Human Embryo: Research Lines and Models

From the Implantation Research Network ‘Fruitful’

Bischof P. · Aplin J.D. · Bentin-Ley U. · Brannstrom M. · Casslen B. · Castrillo J.L. · Classen-Linke I. · Critchley H.O.D. · Devoto L. · D’Hooghe T. · Horcajadas J.A. · Groothuis P. · Ivell R. · Pongrantz I. · Macklon N.S. · Sharkey A. · Vicovac L. · White J.O. · Winterhager E. · von Wolff M. · Simon C. · Stavreus-Evers A.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Infertility is an increasing problem all over the world, and it has been estimated that 10–15% of couples in fertile age have fertility problems. Likewise induced unsafe abortion is a serious threat to women’s health. Despite advances made in assisted reproduction techniques, little progress has been made in increasing the success rate during fertility treatment. This document describes a wide range of projects carried out to increase the understanding in the field of embryo implantation research. The ‘Fruitful’ research network was created to encourage collaborations within the consortium and to describe our different research potentials to granting agencies or private sponsors.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Christenson LK, Devoto L: Cholesterol transport and steroidogenesis by the corpus luteum. Reprod Biol Endocrinol 2003;10:1–9.
  2. Bagchi IC, Kumar S: Steroid-regulated molecular markers of implantation. Semin Reprod Endocrinol 1999;17:235–240.
  3. Klinge CM: Estrogen receptor interaction with co-activators and co-repressors. Steroids 2000;65:227–251.
  4. Lazarus JH: Thyroid dysfunction: reproduction and postpartum thyroiditis. Semin Reprod Med 2002;20:381–388.
  5. Navot D, Bergh P: Preparation of the human endometrium for implantation. Ann NY Acad Sci 1991;622:212–219.
  6. Nordengren J, Pilka R, Noskova V, Ehinger A, Domanski H, Andersson C, Hoyer-Hansen G, Hansson SR, Casslen B: Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle. Mol Hum Reprod 2004;10:655–663.
  7. Bottalico B, Pilka R, Larsson I, Casslen B, Marsal K, Hansson SR: Plasma membrane and vesicular monoamine transporters in normal endometrium and early pregnancy decidua. Mol Hum Reprod 2003;9:389–394.
  8. Das B, Yeger H, Tsuchida R, Torkin R, Gee MF, Thorner PS, Shibuya M, Malkin D, Baruchel S: A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1 alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma. Cancer Res 2005;65:7267–7275.
  9. Nikas G, Makrigiannakis A: Endometrial pinopodes and uterine receptivity. Ann NY Acad Sci 2003;997:120–123.
  10. Stavreus-Evers A, Nikas G, Sahlin L, Eriksson H, Landgren BM: Formation of pinopodes in human endometrium is associated with the concentrations of progesterone and progesterone receptors. Fertil Steril 2001;76:782–791.
  11. Simon C, Oberye J, Bellver J, Vidal C, Bosch E, Horcajadas JA, Murphy C, Adams S, Riesewijk A, Mannaerts B, Pellicer A: Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles. Hum Reprod 2005;20:3318–3327.
  12. Dominguez F, Pellicer A, Simon C: The chemokine connection: hormonal and embryonic regulation at the human maternal-embryonic interface – a review. Placenta 2003;24(suppl B):S48–S55.

    External Resources

  13. Cervero A, Horcajadas JA, Dominguez F, Pellicer A, Simon C: Leptin system in embryo development and implantation: a protein in search of a function. Reprod Biomed Online 2005;10:217–223.
  14. Petersen A, Bentin-Ley U, Ravn V, Qvortrup K, Sorensen S, Islin H, Sjogren A, Mosselmann S, Hamberger L: The antiprogesterone Org 31710 inhibits human blastocyst-endometrial interactions in vitro. Fertil Steril 2005;83(suppl 1):1255–1263.
  15. Stavreus-Evers A, Hovatta O, Eriksson H, Landgren B-M: Development and characterization of a new tissue culture system for human endometrium. Reprod Biomed Online 2003;7:243–249.
  16. Henderson TA, Saunders PT, Moffett-King A, Groome NP, Critchley HO: Steroid receptor expression in uterine natural killer cells. J Clin Endocrinol Metab 2003;88:440–449.
  17. Bischof P, Campana A: A putative role for oncogenes in trophoblast invasion? Hum Reprod 2000;15(suppl 6):51–58.

    External Resources

  18. Pilka R, Domanski H, Hansson S, Eriksson P, Casslen B: Endometrial TIMP-4 mRNA is high at midcycle and in hyperplasia, but down-regulated in malignant tumours. Coordinated expression with MMP-26. Mol Hum Reprod 2004;10:641–650.
  19. Pilka R, Whatling C, Domanski H, Hansson S, Eriksson P, Casslen B: Epithelial expression of matrix metalloproteinase-26 is elevated at mid-cycle in the human endometrium. Mol Hum Reprod 2003;9:271–277.
  20. Cottrell GS, Amadesi S, Schmidlin F, Bunnett N: Protease-activated receptor 2: activation, signalling and function. Biochem Soc Trans 2003;31:1191–1197.
  21. D’Hooghe TM, Debrock S, Kyama CM, Chai DC, Cuneo S, Hill JA, Mwenda JM: Baboon model for fundamental and preclinical research in endometriosis. Gynecol Obstet Invest 2004;57:43–45.
  22. D’Hooghe TM, Debrock S: Future directions in endometriosis research. Obstet Gynecol Clin North Am 2003;30:221–244.
  23. D’Hooghe TM, Nugent N, Cuneo S, Chai DC, Deer F, Debrock S, Kyama CM, Mihalyi A, Mwenda JM: Recombinant Human TNFRSF1A (r-hTBP-1) inhibits the development of endometriosis in baboons: a prospective, randomized, placebo- and drug-controlled study. Biol Reprod 2005 (Epub ahead of print).


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50